The Other 80 Podcast By Claudia Williams cover art

The Other 80

The Other 80

By: Claudia Williams
Listen for free

The Other 80 podcast — brought to you by Claudia Williams at UC Berkeley School of Public Health — hosts real, honest dialogue about the things that help keep people healthy beyond traditional medical care, like housing, social connections and food, and the cutting edge policies, research and programs supporting whole person health. Join former White House advisor, entrepreneur and host Claudia Williams for deep conversations with the innovators, implementers, researchers and policymakers bringing these new models to life. We’ll talk about what’s working, what’s not and how to move towards whole person health rapidly and equitably across the US.Copyright 2026 Claudia Williams Hygiene & Healthy Living Physical Illness & Disease Political Science Politics & Government
Episodes
  • Patient Agency in the Age of AI with Liz Salmi & Hugo Campos

    Patient Agency in the Age of AI with Liz Salmi & Hugo Campos
    Mar 25 2026
    Patient innovators Liz Salmi and Hugo Campos join The Other 80 to discuss the evolving role of patients in healthcare, using the recent release of ChatGPT Health as a central lens. They delve into how AI is shifting the power dynamic by enabling greater patient agency and creating new expectations for health systems. Drawing on their personal experiences, including Liz's work with OpenNotes and Hugo's long struggle for access to his cardiac device data, they explore how technology can serve as a bridge for collaboration, rather than a source of conflict, between patients and clinicians. Claudia, Liz and Hugo talk about:How patients who are sick and scared often choose sharing over privacyWhy Hugo still can’t access his implanted device dataThe need for a new doctor-patient relationship grounded in collaboration, not controlLiz says AI is surfacing the same reactions she saw around patients googling health information:“It makes me think of the Dr. Google era of when clinicians were like, ‘patients shouldn't go online and look for information about their own health because they don't know how to search accurately for their own health information’. And I think we're at this early stage of the tension between health systems wanting to still control how patients find their own health information, versus our own curiosity and exploration of digging into our own health information and… asking the questions that are important to us and then discovering the answers ourselves in our own journey.”Relevant LinksRead Liz and Hugo’s paper on Critical AI Health LiteracyWatch Hugo’s TEDx Talk on Fighting for the Right to Open His Heart DataLearn more about the patient data transparency movement at OpenNotesRead the full text of the 21st Century Cures ActAbout Our GuestsHugo Campos is an internationally recognized patient advocate, combining creative and technical expertise to promote participatory medicine and patient-centered, AI-enabled healthcare. Named a White House Champion of Change for Precision Medicine by President Obama in 2015, he advocates for patient rights and health data access while managing his own cardiac condition. Hugo serves on the NIH’s All of Us Research Program Steering Committee, co-leads patient engagement for PCORI’s THRIVE trial, and advises UCSF/UC Berkeley’s Computational Precision Health program. A TEDx Cambridge speaker, his advocacy has been featured in national media and scientific publications. Hugo lives in Oakland, California, with his husband, elderly father, and Memphis the cat.SourceLiz Salmi is the Communications & Patient Initiatives Director for OpenNotes. In this role, Liz helps clinicians, hospitals and health systems understand through “the patient’s eyes” the changing nature of patient-clinician communication in an age of growing transparency. Her research areas of interest include: the effects of transparency on patient-clinician communication, stakeholder engagement, research dissemination, and the role of social media in patient-clinician-researcher collaborations.As a person living with a low grade malignant brain tumor, Liz is passionate about helping all people engage in their own health care by improving their experience as patients. Over the last 17 years she has been: a research subject; an advisor in patient stakeholder groups; a leader in “patient engagement” research initiatives; and an innovator, educator and investigator in national educational and research projects.In addition to her work with OpenNotes, Liz led the Brain Cancer Quality of Life Collaborative, a multi-stakeholder group dedicated to advancing science and improving the quality of life for people with malignant brain tumors. In fall 2021, members of the BCQoLC team (along with established investigators), were awarded a $12.8 million Center Grant from the National Cancer Institute to determine optimal methods for patient enrollment in a brain tumor registry.SourceConnect With UsFor more information on The Other 80 please visit our website - www.theother80.com. To connect with our team, please email claudia@theother80.com and follow us on twitter @claudiawilliams and LinkedInSubscribe to The Other 80 on YouTube so you never miss our video extras or special video episodes!
    Show more Show less
    42 mins
  • Missing the Nobel Call with Fred Ramsdell

    Missing the Nobel Call with Fred Ramsdell
    Mar 11 2026
    Newly-minted Nobel laureate Fred Ramsdell joins Claudia to discuss his groundbreaking work on regulatory T cells, which act as the immune system's natural "brakes." His research aims to "reset" the immune system to cure autoimmune diseases (like rheumatoid arthritis and MS) moving beyond mere symptom management. Fred reflects on his new role as a science advocate, addressing the crisis of public trust in science and the need for greater diversity in biomedical research.During this conversation, recorded at the UC Berkeley/JP Morgan Healthcare Conference in Taipei, Claudia and Fred discuss:How Fred missed the Nobel Prize call while off-grid campingHis shifting goals in retirement post Nobel winWhy he chose biotech: collaboration, speed, and being "wrong fast"The deeper threat to science: funding vs. trust, and his surprise in SwedenFred says he’s excited to see what other advances are possible in what he calls “the early innings” of scientific discovery:“As humans, we're really good at solving technological problems. If we know what the problem is, historically, we're pretty good at figuring out an answer. [We’re] pretty confident now that we know the problem in peripheral tolerance, that is the breakdown of our immune system recognizing our own tissues. Now we know what at least part of that problem is, we'll be able to engineer our way into a solution.”Relevant LinksSee more about Fred’s Nobel win and read the UCLA press releaseFred’s Nobel prize lectureSee Fred and his co-laureates accept their prizeRead more about Fred’s 2025 co-laureates Mary E. Brunkow and Shimon SakaguchiAbout Our GuestFred Ramsdell, PhD, is a veteran biotechnology leader in immunology with nearly three decades of experience and was named a winner of the 2025 Nobel Prize in Physiology or Medicine. A co-founder of Sonoma Biotherapeutics, Dr. Ramsdell was the former Chief Scientific Officer (CSO) and current Scientific Advisory Board Chair of the Company.Dr. Ramsdell earned his doctoral degree in microbiology and immunology from the University of California, Los Angeles and holds a bachelor’s degree in biochemistry and cell biology from the University of California, San Diego. Following a fellowship at the NIH, Dr. Ramsdell joined Immunex studying T cell activation and tolerance, with a focus on gene discovery and functional characterization. He later joined Darwin Molecular (which was later acquired by Celltech R&D) to establish the immunology program. Amongst other programs, he led the team that discovered and characterized FoxP3, a gene critical to the function of regulatory T cells. Dr. Ramsdell joined ZymoGenetics in 2004, where he led teams studying novel proteins with potential regulatory activity in lymphoid cells. In 2008, Novo Nordisk brought on Dr. Ramsdell to help establish the company’s new Inflammation Research Center in Seattle and lead the Immunobiology group. Prior to SonomaBio, Dr. Ramsdell was the CSO at the Parker Institute for Cancer Immunotherapy (PICI) where he helped to build and advance multiple research programs from the inception of the Institute.SourceConnect With UsFor more information on The Other 80 please visit our website - www.theother80.com. To connect with our team, please email claudia@theother80.com and follow us on twitter @claudiawilliams and LinkedInSubscribe to The Other 80 on YouTube so you never miss our video extras or special video episodes!
    Show more Show less
    39 mins
  • Breaking the Cycle of Homelessness with Kunal Modi

    Breaking the Cycle of Homelessness with Kunal Modi
    Feb 25 2026
    When Mayor Lurie took office, San Francisco was spending nearly $1 Billion a year responding to homelessness, yet the number of people living unsheltered had not budged in years. In this episode, Kunal Modi, the city’s Chief of Health and Human Services, shares how the Lurie administration is tackling the intersecting homelessness, mental health and addiction crises. Rather than layering on new programs, the city is attempting something harder: redesigning how fragmented systems work together.Kunal and Claudia discuss:The city’s move to unify fragmented and siloed outreach teamsThe importance of shifting accountability and decision-making to the front linesHow San Francisco’s strategy is leveraging the community supports in CalAIMWhy solutions need to reflect the intersecting nature of the homeless problemKunal reminds us that ending the cycle of homelessness is far more complicated than just finding housing:“This is more than a homelessness crisis, it's an intersecting homelessness, behavioral health, and drug addiction crisis that we need to bring our healthcare system and our social service system in closer alignment… We need to reorient our Public Health strategies to not only support those in crisis, but to think about the broader communities and neighborhoods.”Relevant LinksSee Mayor Lurie’s thoughts on the “Breaking the Cycle” initiativeGet more information on the City’s new RV parking restrictionsRead the Crankstart report on tackling homelessness in San Francisco About Our GuestKunal Modi is the policy chief of health, homelessness, and family services in San Francisco Mayor Daniel Lurie’s administration. In this role, he coordinates eight agencies, including the Department of Homelessness and Supportive Housing, the Department of Children, Youth and Families and the Department of Early Childhood, while also serving as liaison to San Francisco Unified School District and City College. He brings extensive experience in cross-agency collaboration and reform, aiming to deliver compassionate, effective solutions for the city’s most pressing health, housing, and family needs. Before joining City Hall, he spent over 11 years as a partner at McKinsey & Company’s Bay Area office and previously served on the boards of Larkin Street Youth Services and St. Anthony’s Foundation. His educational background includes an M.B.A. from Harvard Business School, an M.P.P. from Harvard Kennedy School, and a B.A. from Northwestern University.Connect With UsFor more information on The Other 80 please visit our website - www.theother80.com. To connect with our team, please email claudia@theother80.com and follow us on twitter @claudiawilliams and LinkedInSubscribe to The Other 80 on YouTube so you never miss our video extras or special video episodes!
    Show more Show less
    41 mins
No reviews yet